Legend Biotech and Noile-Immune Biotech Announce Collaborative Research and Licensing Agreement Read more
Glenmark Initiates Phase 3 Clinical Trials on Antiviral Favipiravir for COVID-19 Patients in India Read more
Seattle Genetics gets approval of TUKYSA in Switzerland for metastatic HER2-positive breast cancer Read more
Moderna Receives FDA Fast Track Designation for mRNA Vaccine (mRNA-1273) Against Novel Coronavirus Read more
Sarclisa (isatuximab) Phase 3 IKEMA trial meets primary endpoint early in patients with relapsed multiple myeloma Read more